Design Expert Software Empowering Ocular Drug Delivery: Learning From Past Successes With Ocular Inserts

  • Maddileti Repollu Research Scholar, Department of Pharmaceutical Sciences, Jawaharlal Nehru Technological University, Anantapur, Ananthapuramu, Andhra Pradesh, India.
  • Haranath Chinthaginjala Department of Pharmaceutics, Raghavendra Institute of Pharmaceutical Education and Research (RIPER)-Autonomous, Ananthapuramu, Andhra Pradesh, India.
Keywords: Bioavailability, Innovative Drug Delivery, Ocular Insert, Polymers


The primary objective of this review is to explore the techniques adopted that can slow down the excretion of drugs from the ocular surface and prolong the contact time of the medication with the target tissues. Ocular inserts have emerged as a promising approach in this regard and can be broadly categorised into three types: soluble, insoluble, and biodegradable ocular inserts. In the field of ophthalmic formulations, conventional dosage forms are widely used, accounting for approximately 90% of the products available in the market. However, one of the main challenges faced with conventional formulations is the rapid loss of medication from the cornea, leading to reduced bioavailability and efficacy of ocular medications. To overcome this challenge and improve the delivery of ocular medications, significant efforts have been focused on the development of novel drug delivery systems specifically designed for ophthalmic administration. Recent studies in this area have explored the combination of different drug delivery technologies to achieve enhanced therapeutic outcomes. Overall, the development of ocular inserts represents a significant advancement in the treatment of various eye diseases. These inserts offer the potential to improve drug bioavailability, prolong therapeutic effects, and enhance patient compliance by reducing the frequency of administration. The work summarises that further research and development efforts are needed in this field to refine these technologies and optimise their effectiveness in ocular drug delivery.

How to cite this article:
Repollu M, Chinthaginjala H. Design Expert Software Empowering Ocular Drug Delivery: Learning From Past Successes With Ocular Inserts. Chettinad Health City Med J. 2024;13(2):81-91.



Kumar KP, Bhowmik D, Harish G, Duraivel S, Kumar BP. Ocular inserts: a novel controlled drug delivery system. Pharma Innov J. 2013;1(12):1. [Google Scholar]

Banu S, Ayesha FS. Ocular drug delivery system: a novel approach. Asian J Res Pharm Sci. 2019;9(2):97-106. [Google Scholar]

Kalugade D, Kamthe K, More A, Jograna M, Bhosale A. A review: ocular drug delivery system. Int J Pharm Res Appl. 2021;6(3):678-90.

Bhattacharya S, Sagi AR, Gutta M, Chiruvella R, Boinpally RR. Programmable drug delivery systems. In: Li X, Jasti BR, editors. Design of controlled release drug delivery systems. McGraw-Hill; 2006:405. [Google Scholar]

Kaushik S. An in situ gelling system for the extended delivery of ophthalmic drugs [dissertation]. University of Nebraska Medical Center; 1998. [Google Scholar]

Devhadrao NV, Siddhaia M. Review on ocular insert drug delivery system. J Drug Deliv Ther. 2018;8(5-s):115-21. [Google Scholar]

Ribeiro AM, Figueiras A, Veiga F. Improvements in topical ocular drug delivery systems: hydrogels and contact lenses. J Pharm Pharm Sci. 2015;18(5):683-95. [PubMed] [Google Scholar]

Khan A, Raza SN, Itoo A, Bashir S, Wani TU, Khan NA. Ocular inserts-a novel approach in ocular drug delivery. J Drug Deliv Ther. 2019;9(4):693-703. [Google Scholar]

Patel A, Patel D, Patel N, Patel J, Patel M, Patel A. Novel ophthalmic drug delivery approach: an ophthalmic inserts. Res J Pharm Technol. 2012;5(6):729-35. [Google Scholar]

Rathore KS, Nema RK. Review on ocular inserts. Int J PharmTech Res. 2009;1(2):164-9. [Google Scholar]

Alzahrani A, Youssef AA, Nyavanandi D, Tripathi S, Bandari S, Majumdar S, Repka MA. Design and optimization of ciprofloxacin hydrochloride biodegradable 3D printed ocular inserts: full factorial design and in-vitro and ex-vivo evaluations: part II. Int J Pharm. 2023;631:122533. [PubMed] [Google Scholar]

Shoman NA, Gebreel RM, El-Nabarawi MA, Attia A. Optimization of hyaluronan-enriched cubosomes for bromfenac delivery enhancing corneal permeation: characterization, ex vivo, and in vivo evaluation. Drug Deliv. 2023;30(1):2162162. [PubMed] [Google Scholar]

Hanagandi V, Patil AS, Masareddy RS, Dandagi PM, Bolmal UB. Development and evaluation of nanosuspension incorporated in situ gel of brimonidine tartarate for ocular drug delivery. Indian J Pharm Educ Res. 2022;56(1):94-102. [Google Scholar]

Shukr MH, Ismail S, El-Hossary GG, El-Shazly AH. Design and evaluation of mucoadhesive in situ liposomal gel for sustained ocular delivery of travoprost using two steps factorial design. J Drug Deliv Sci Technol. 2021;61:102333. [Google Scholar]

Thakkar R, Komanduri N, Dudhipala N, Tripathi S, Repka MA, Majumdar S. Development and optimization of hot-melt extruded moxifloxacin hydrochloride inserts, for ocular applications, using the design of experiments. Int J Pharm. 2021;603:120676. [PubMed] [Google Scholar]

Fernandes AR, Sanchez-Lopez E, Santini A, Santos TD, Garcia ML, Silva AM, Souto EB. Mono- and dicationic DABCO/Quinuclidine composed nanomaterials for the loading of steroidal drug: 32 factorial design and physicochemical characterization. Nanomaterials (Basel). 2021;11(10):2758. [PubMed] [Google Scholar]

Youshia J, Kamel AO, El Shamy A, Mansour S. Gamma sterilization and in vivo evaluation of cationic nanostructured lipid carriers as potential ocular delivery systems for antiglaucoma drugs. Eur J Pharm Sci. 2021;163:105887. [PubMed] [Google Scholar]

Albash R, Al-Mahallawi AM, Hassan M, Alaa-Eldin AA. Development and optimization of terpene-enriched vesicles (terpesomes) for effective ocular delivery of fenticonazole nitrate: in vitro characterization and in vivo assessment. Int J Nanomedicine. 2021;16:609. [PubMed] [Google Scholar]

Suriyaamporn P, Opanasopit P, Ngawhirunpat T, Rangsimawong W. Computer-aided rational design for optimally GantrezĀ® S-97 and hyaluronic acid-based dissolving microneedles as a potential ocular delivery system. J Drug Deliv Sci Technol. 2021;61:102319. [Google Scholar]

Said M, Aboelwafa AA, Elshafeey AH, Elsayed I. Central composite optimization of ocular mucoadhesive cubosomes for enhanced bioavailability and controlled delivery of voriconazole. J Drug Deliv Sci Technol. 2021;61:102075. [Google Scholar]

Kendre PN, Kadam PD, Jain SP, Vibhute SK, Pote AK. Design, fabrication, and characterization of graft co-polymer assisted ocular insert: a state of art in reducing post-operative pain. Drug Dev Ind Pharm. 2020;46(12):1988-99. [PubMed] [Google Scholar]

Patil AV. Novel ophthalmic formulations for improved natamycin delivery in fungal infections of the eye [dissertation]. University of Mississippi; 2020. [Google Scholar]

Jadhav RL. Formulation optimization and evaluation of ocular inserts prepared with sulfoxyamine modified chitosan. Asian J Pharm. 2020;14(2). [Google Scholar]

Majumdar S, Swain S, Rao ME, Chakraborty P, Das SS. Acyclovir loaded solid lipid nanoparticulate gel for ocular delivery: optimization by using factorial design. Indian J Pharm Educ Res. 2021;55(1):S122-34. [Google Scholar]

Kurniawansyah IS, Rusdiana T, Sopyan I, Ramoko H, Wahab HA, Subarnas A. In situ ophthalmic gel forming systems of poloxamer 407 and hydroxypropyl methyl cellulose mixtures for sustained ocular delivery of chloramphenicole: optimization study by factorial design. Heliyon. 2020;6(11):e05365. [PubMed] [Google Scholar]

Bhattacharjee A, Das PJ, Dey S, Nayak AK, Roy PK, Chakrabarti S, Marbaniang D, Das SK, Ray S, Chattopadhyay P, Mazumder B. Development and optimization of besifloxacin hydrochloride loaded liposomal gel prepared by thin film hydration method using 32 full factorial design. Colloids Surf A Physicochem Eng Asp. 2020;585:124071. [Google Scholar]

Mittal N, Kaur G. Investigations on polymeric nanoparticles for ocular delivery. Adv Polym Technol. 2019;2019:1316249. [Google Scholar]

Patil A, Lakhani P, Taskar P, Avula B, Majumdar S. Carboxyvinyl polymer and guar-borate gelling system containing natamycin loaded PEGylated nanolipid carriers exhibit improved ocular pharmacokinetic parameters. J Ocul Pharmacol Ther. 2020;36(6):410-20. [PubMed] [Google Scholar]

Patil SS, Bade A, Tagalpallewar A. Design, optimization and pharmacodynamic comparison of dorzolamide hydrochloride soluble ocular drug insert prepared by using 32 factorial designs. J Drug Deliv Sci Technol. 2018;46:138-47. [Google Scholar]

Fouda NH, Abdelrehim RT, Hegazy DA, Habib BA. Sustained ocular delivery of Dorzolamide-Cl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits. Drug Deliv. 2018;25(1):1340-9. [PubMed] [Google Scholar]

Ranch K, Patel H, Chavda L, Koli A, Maulvi F, Parikh RK. Development of in situ ophthalmic gel of dexamethasone sodium phosphate and chloramphenicol: a viable alternative to conventional eye drops. J Appl Pharm Sci. 2017;7(3):101-8. [Google Scholar]

Khalil RM, Abdelbary GA, Basha M, Awad GE, El-Hashemy HA. Enhancement of lomefloxacin Hcl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation. J Liposome Res. 2017;27(4):312-23. [PubMed] [Google Scholar]

Zadeh BS, Niro H, Rahim F, Esfahani G. Ocular delivery system for propranolol hydrochloride based on nanostructured lipid carrier. Sci Pharm. 2018;86(2):16. [PubMed] [Google Scholar]

ElShaer A, Mustafa S, Kasar M, Thapa S, Ghatora B, Alany RG. Nanoparticle-laden contact lens for controlled ocular delivery of prednisolone: formulation optimization using statistical experimental design. Pharmaceutics. 2016;8(2):14. [PubMed] [Google Scholar]

Patel N, Nakrani H, Raval M, Sheth N. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability. Drug Deliv. 2016;23(9):3712-23. [PubMed] [Google Scholar]

Al-Saedi ZH, Alzhrani RM, Boddu SH. Formulation and in vitro evaluation of cyclosporine-a inserts prepared using hydroxypropyl methylcellulose for treating dry eye disease. J Ocul Pharmacol Ther. 2016;32(7):451-62. [PubMed] [Google Scholar]

Barse R, Kokare C, Tagalpallewar A. Influence of hydroxypropylmethylcellulose and poloxamer composite on developed ophthalmic in situ gel: ex vivo and in vivo characterization. J Drug Deliv Sci Technol. 2016;33:66-74. [Google Scholar]

Saher O, Ghorab DM, Mursi NM. Levofloxacin hemihydrate ocular semi-sponges for topical treatment of bacterial conjunctivitis: formulation and in-vitro/ in-vivo characterization. J Drug Deliv Sci Technol. 2016;31:22-34. [Google Scholar]

Katpale Avinash T, Ajay S. Formulation and evaluation of thermoreversible in situ ocular gel of clonidine hydrochloride for glaucoma. Pharmacophore. 2015;6(5):220-32. [Google Scholar]

Dol H, Gandhi S, Pardhi D, Vyawahare N. Formulation and evaluation of in situ ophthalmic gel of moxifloxacin hydrochloride. Pharma Innov. 2014;3(5):60. [Google Scholar]

Hermans K, Van den Plas D, Kerimova S, Carleer R, Adriaensens P, Weyenberg W, Ludwig A. Development and characterization of mucoadhesive chitosan films for ophthalmic delivery of cyclosporine A. Int J Pharm. 2014;472(1-2):10-9. [PubMed] [Google Scholar]

Patel PJ, Gohel MC, Acharya SR. Exploration of statistical experimental design to improve entrapment efficiency of acyclovir in poly (d, l) lactide nanoparticles. Pharm Dev Technol. 2014;19(2):200-12. [PubMed] [Google Scholar]

Basha M, Abd El-Alim SH, Shamma RN, Awad GE. Design and optimization of surfactant-based nanovesicles for ocular delivery of clotrimazole. J Liposome Res. 2013;23(3):203-10. [PubMed] [Google Scholar]

Fangueiro JF, Andreani T, Egea MA, Garcia ML, Souto SB, Silva AM, Souto EB. Design of cationic lipid nanoparticles for ocular delivery: development, characterization and cytotoxicity. Int J Pharm. 2014;461(1-2):64-73. [PubMed] [Google Scholar]

Parejiya PB, Patel RC, Mehta DM, Shelat PK, Barot BS. Quick dissolving films of nebivolol hydrochloride: formulation and optimization by a simplex lattice design. J Pharm Investig. 2013;43(4):343-51. [Google Scholar]

Hermans K, Van den Plas D, Everaert A, Weyenberg W, Ludwig A. Full factorial design, physicochemical characterisation and biological assessment of cyclosporine A loaded cationic nanoparticles. Eur J Pharm Biopharm. 2012;82(1):27-35. [PubMed] [Google Scholar]

Mistry GS, Patel SD, Tank HM, Matushree VB, Dumiyani R. Formulation and evaluation of ocular insert of acyclovir. PharmaTutor. 2012;24.

Ghelani TK, Seth AK, Saini V, Kumar S, Yadav YC, Singhal S. Design and optimization of timolol maleate ocular insert by statistical 32 factorial design. Acta Pharm Sci. 2011;53(4):577-92. [Google Scholar]

Kaur H, Ahuja M, Kumar S, Dilbaghi N. Carboxymethyl tamarind kernel polysaccharide nanoparticles for ophthalmic drug delivery. Int J Biol Macromol. 2012;50(3):833-9. [PubMed] [Google Scholar]

Gonjari ID, Karmarkar AB, Khade TS, Hosmani AH, Navale RB. Use of factorial design in formulation and evaluation of ophthalmic gels of gatifloxacin: comparison of different mucoadhesive polymers. Drug Discov Ther. 2010;4(6):423-34. [PubMed] [Google Scholar]

Nasr M, Teiama M, Ismail A, Ebada A, Saber S. In vitro and in vivo evaluation of cubosomal nanoparticles as an ocular delivery system for fluconazole in treatment of keratomycosis. Drug Deliv Transl Res. 2020;10(6):1841-52. [PubMed] [Google Scholar]

Shivakumar HN, Desai BG, Subhash PG, Ashok P, Hulakoti B. Design of ocular inserts of brimonidine tartrate by response surface methodology. J Drug Deliv Sci Technol. 2007;17(6):421-30. [Google Scholar]

Kannan SK, Duraisamy D, Sudhakar Y. Optimization of 32 full factorial design based norfloxacin nanoparticles embedded thermo sensitive droppable gel for ocular drug delivery. World J Pharm Res. 2017;6(10):1793-821. [Google Scholar]